Pharmacokinetics and population pharmacokinetics in pediatric oncology
Open Access
- 25 December 2019
- journal article
- review article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 67 (4) , e28132
Abstract
Pharmacokinetic research has become increasingly important in pediatric oncology as it can have direct clinical implications and is a crucial component in individualized medicine. Population pharmacokinetics has become a popular method especially in children, due to the potential for sparse sampling, flexible sampling times, computing of heterogeneous data, and identification of variability sources. However, population pharmacokinetic reports can be complex and difficult to interpret. The aim of this article is to provide a basic explanation of population pharmacokinetics, using clinical examples from the field of pediatric oncology, to facilitate the translation of pharmacokinetic research into the daily clinic.Keywords
Funding Information
- Go4Children Foundation
- Children Cancer-free (KiKa) Foundation
This publication has 113 references indexed in Scilit:
- Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development: Part 3—Introduction to Pharmacodynamic Modeling MethodsCPT: Pharmacometrics & Systems Pharmacology, 2014
- Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and DevelopmentCPT: Pharmacometrics & Systems Pharmacology, 2013
- Pharmacokinetic Behavior and Appraisal of Intravenous Busulfan Dosing in Infants and Older ChildrenTherapeutic Drug Monitoring, 2012
- A Bodyweight-Dependent Allometric Exponent for Scaling Clearance Across the Human Life-SpanPharmaceutical Research, 2012
- Interpreting population pharmacokinetic‐pharmacodynamic analyses – a clinical viewpointBritish Journal of Clinical Pharmacology, 2011
- Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and AdultsPharmaceutics, 2011
- Modelling and simulation as research tools in paediatric drug developmentEuropean Journal of Clinical Pharmacology, 2011
- Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric StudiesAntimicrobial Agents and Chemotherapy, 2009
- Population pharmacokinetic and pharmacogenetic analysis of 6‐mercaptopurine in paediatric patients with acute lymphoblastic leukaemiaBritish Journal of Clinical Pharmacology, 2008
- Developmental pharmacokinetics of ciclosporin – a population pharmacokinetic study in paediatric renal transplant candidatesBritish Journal of Clinical Pharmacology, 2007